please direct me to a link perhaps?
Clinical pharmacokinetics and pharmacodynamics of rifampicin in human tuberculosis
About the Author: Julia Lloyd, MPH, RD, LDN, CDCES, is a registered dietitian and diabetes educator specializing in GLP-1 counseling
Renal Considerations Isolated case reports have described rhabdomyolysis (muscle breakdown) in individuals using Melanotan II, though these cases often involved confounding factors such as extreme exercise or dehydration
Although traditionally considered to have limited efficacy in patients with diabetes, recent studies indicate that, when acting synergistically with GLP-1, GIP enhances insulinotropic effects and improves overall metabolic homeostasis (20, 21)